Farther Finance Advisors’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $66.8K | Buy |
910
+669
| +278% | +$49.1K | ﹤0.01% | 1981 |
|
|
2025
Q1 | $22.1K | Buy |
241
+72
| +43% | +$6.62K | ﹤0.01% | 2340 |
|
|
2024
Q4 | $8.52K | Sell |
169
-89
| -34% | -$4.49K | ﹤0.01% | 2445 |
|
|
2024
Q3 | $11.9K | Sell |
258
-2,479
| -91% | -$115K | ﹤0.01% | 2297 |
|
|
2024
Q2 | $89.4K | Buy |
2,737
+2,632
| +2,507% | +$86K | ﹤0.01% | 1177 |
|
|
2024
Q1 | $2.7K | Sell |
105
-28
| -21% | -$721 | ﹤0.01% | 2364 |
|
|
2023
Q4 | $4.32K | Buy |
133
+27
| +25% | +$877 | ﹤0.01% | 2045 |
|
|
2023
Q3 | $2.89K | Buy |
106
+5
| +5% | +$136 | ﹤0.01% | 1717 |
|
|
2023
Q2 | $2.25K | Hold |
101
| – | – | ﹤0.01% | 1716 |
|
|
2023
Q1 | $2.19K | Hold |
101
| – | – | ﹤0.01% | 1614 |
|
|
2022
Q4 | $2.05K | Buy |
+101
| New | +$2.05K | ﹤0.01% | 1439 |
|